Effects of denosumab versus zoledronic acid (ZA) on health-related quality of life (HRQL) in metastatic breast cancer: Results from a randomized phase III trial.
暂无分享,去创建一个
L. Fallowfield | D. Patrick | J. Body | K. Tonkin | A. Lipton | Y. Qian | K. Chung | R. Dansey | Q. Jiang